Files
2026-07-06 17:27:20 -04:00

71 lines
3.2 KiB
Markdown
Raw Permalink Blame History

This file contains ambiguous Unicode characters
This file contains Unicode characters that might be confused with other characters. If you think that this is intentional, you can safely ignore this warning. Use the Escape button to reveal them.
---
type: "Bill"
title: "Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product"
description: "Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product"
jurisdiction: "us/states/md"
legislature: "Maryland General Assembly"
session: "2021"
identifier: "HB 429"
citation: "Maryland HB 429 (2021)"
classification: ["bill"]
subjects: []
status: "enacted"
primary_sponsors: ["Shetty"]
version_count: 3
action_count: 13
vote_count: 2
first_action: "2021-01-15"
last_action: "2021-05-18"
source: "openstates"
source_identifier: "ocd-bill/b7a8d71f-a285-4f1b-bdf2-1d1bc311fb5a"
source_url: "http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/hb0429?ys=2021RS&search=True"
source_hash: "2212f340869b974b0d95a886c9a907b48304eaa3c415bf5f988078c3e40d79be"
vintage: "2026-07-01"
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
retrieved_at: "2026-07-06"
confidence: "reported"
tags: ["legislation", "bill", "us-md"]
---
# Maryland HB 429 (2021) — Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product
## Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
1. **Chapter - Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product** (committee substitute) — [source](http://mgaleg.maryland.gov/2021RS/Chapters_noln/CH_162_hb0429t.pdf)
2. **First - Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product** (committee substitute) — [source](http://mgaleg.maryland.gov/2021RS/bills/hb/hb0429f.pdf)
3. **Third - Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product** (committee substitute) — [source](http://mgaleg.maryland.gov/2021RS/bills/hb/hb0429t.pdf)
## Votes
- On Third Reading — **1280** (pass) · lower
- On Third Reading — **450** (pass) · upper
## Sponsors
- Shetty — primary (person)
## Timeline
The legislative action history — every referral, reading, and vote.
- **2021-01-15** First Reading Health and Government Operations `referral-committee`
- **2021-01-21** Hearing 2/03 at 2:30 p.m.
- **2021-02-24** Favorable with Amendments Report by Health and Government Operations `committee-passage-favorable`
- **2021-02-25** Favorable with Amendments { `committee-passage-favorable`
- **2021-02-25** Second Reading Passed with Amendments
- **2021-02-26** Third Reading Passed `passage`
- **2021-03-02** Referred Education, Health, and Environmental Affairs `referral-committee`
- **2021-04-10** Favorable Report by Education, Health, and Environmental Affairs `committee-passage-favorable`
- **2021-04-10** Favorable Adopted `committee-passage-favorable`
- **2021-04-10** Second Reading Passed
- **2021-04-12** Third Reading Passed `passage`
- **2021-04-12** Returned Passed
- **2021-05-18** Approved by the Governor - Chapter 162 `executive-signature`
## Source
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/b7a8d71f-a285-4f1b-bdf2-1d1bc311fb5a`. Confidence: reported (aggregated from official Maryland legislature records).